Ivermectin reverses the drug resistance in cancer cells through EGFR/ERK/Akt/NF-κB pathway

BACKGROUND: Discovery and development of novel drugs that are capable of overcoming drug resistance in tumor cells are urgently needed clinically. In this study, we sought to explore whether ivermectin (IVM), a macrolide antiparasitic agent, could overcome the resistance of cancer cells to the thera...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Lu, Wang, Pan, Sun, Ying-Jian, Wu, Yi-Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6580523/
https://www.ncbi.nlm.nih.gov/pubmed/31215501
http://dx.doi.org/10.1186/s13046-019-1251-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6580523/
https://www.ncbi.nlm.nih.gov/pubmed/31215501
http://dx.doi.org/10.1186/s13046-019-1251-7

Ejemplares similares